RSS Items

Decision is a blow to Starmer’s government after setting out pro-growth pitch to investors

Vaccine recipient claims he suffered side effect of severe blood clot

Drugmaker upbeat on full data after initial findings disappointed investors

Lawsuit claims UK pharma giant understated the risk of government investigations

Drugmaker has benefited from its bet on developing a portfolio of cancer drugs

FTSE 100 group reportedly faces difficulties in selling drugs to Chinese hospitals

Gracell Biotechnologies would operate as wholly owned subsidiary under terms of deal

Almost 36 per cent of shareholders voted against a £1.8mn rise for the pharma group’s boss

Shareholder advisory groups say potential £18.7mn payout is excessive

Investigation of group’s China chief Leon Wang continues after several employees were found guilty of fraud